Back to search

Article

Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies

2022-11-21

Abstract excerpt

<title>Abstract</title> <p>Erdheim-Chester disease (ECD) is a rare histiocytosis due to proto-oncogene mutations, primarily affecting the long bones and possibly being treated by novel targeted therapies. <sup>18</sup>F-FDG PET is a reference technique for ECD assessment. However, we present a case where easier and more objective monitoring of the ECD-related bone metabolism abnormalities under treatment was obta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5d9837c7-dcc8-598c-a8c3-1cadef6e64eb
DOI
10.21203/rs.3.rs-2275243/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphiesDOI 10.21203/rs.3.rs-2275243/v1
Select a neighboring publication to make it the new centre.